Parkinson's Disease (PD)
Also known as: Parkinson's Disease (Disorder) / Parkinson's / Parkinson's Disease / Parkinson's Syndrome / PD - Parkinson's Disease / Parkinsons's Disease / Parkinson disease / Parkinson's dis / Hemiparkinsonism / Parkinson's disease NOS / Parkinson's disease NOS (disorder) / Palsy shaking / Paralysis agitans / Disease Parkinson's / Syndrome Parkinson's / Parkinsonian Disorders / Parkinsonism (finding) / Parkinsonism / Parkinsonism (disorder) / Hypokinetic-rigid syndrome
Drug | Drug Name | Drug Description |
---|---|---|
DB00915 | Amantadine | A medication used to treat dyskinesia in Parkinson's patients receiving levodopa, as well as extrapyramidal side effects of medications. |
DB00714 | Apomorphine | A morphine derivative D2 dopamine agonist used to treat hypomobile "off" episodes of advanced Parkinson's disease. |
DB12783 | Benserazide | A medication used to treat Parkinson's disease, parkinsonism, and restless leg syndrome. |
DB00810 | Biperiden | A muscarinic receptor antagonist used to treat parkinsonism and control extrapyramidal side effects of neuroleptic drugs. |
DB13619 | Bornaprine | An anticholinergic drug indicated in the treatment of hyperhidrosis, dyskinesia, akathisia, parkinsonism, and Parkinson's disease. |
DB01200 | Bromocriptine | A dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome. |
DB00190 | Carbidopa | A dopa decarboxylase inhibitor used in combination with levodopa for the symptomatic treatment of idiopathic Parkinson disease and other conditions associated with parkinsonian symptoms. |
DB06262 | Droxidopa | A medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease. |
DB00494 | Entacapone | A selective reversible catechol-O-methyltransferase inhibitor for the treatment of Parkinson's disease. |
DB11757 | Istradefylline | A selective adenoside A2A receptor antagonist indicated in adjunct to levodopa and carbidopa for the treatment of Parkinson's Disease. |
DB01235 | Levodopa | A dopamine precursor used in the management of Parkinson's disease, often in combination with carbidopa, as well as other conditions associated with parkinsonism. |
DB13313 | Melevodopa | A methyl ester of levodopa indicated in combination with carbidopa for the treatment of Parkinson's disease. |
DB11632 | Opicapone | A catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson's Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor. |
DB01186 | Pergolide | A long-acting dopamine agonist that is uncommonly used for the management of Parkinson's disease, due to the risk for cardiac valvulopathy. |
DB12478 | Piribedil | A dopamine agonist used with or without levodopa in the treatment of Parkinson's disease. |
DB00413 | Pramipexole | A non-ergot dopamine agonist used to treat the signs and symptoms of idiopathic Parkinson's disease and Restless Legs Syndrome (RLS). |
DB01224 | Quetiapine | A psychotropic agent used for the management of bipolar disorder, schizophrenia, and major depressive disorder. |
DB01367 | Rasagiline | An irreversible inhibitor of monoamine oxidase used for the symptomatic management of idiopathic Parkinson's disease as initial monotherapy and as adjunct therapy to levodopa. |
DB00268 | Ropinirole | A non-ergoline dopamine agonist used to treat the symptoms of Parkinson's disease and Restless Legs Syndrome. |
DB05271 | Rotigotine | A non-selective dopamine agonist used for the treatment of Parkinson's Disease and Restless Leg Syndrome. |
DB06654 | Safinamide | A MAO-B inhibitor used as an add-on treatment to levodopa/carbidopa for Parkinson's disease during "off" episodes. |
DB01037 | Selegiline | A monoamine oxidase inhibitor used to treat major depressive disorder and Parkinson's. |